A detailed history of Formula Growth LTD transactions in Vericel Corp stock. As of the latest transaction made, Formula Growth LTD holds 26,824 shares of VCEL stock, worth $1.59 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
26,824
Previous 44,700 39.99%
Holding current value
$1.59 Million
Previous $2.05 Million 44.73%
% of portfolio
0.41%
Previous 0.79%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.25 - $53.56 $755,261 - $957,438
-17,876 Reduced 39.99%
26,824 $1.13 Million
Q2 2024

Aug 13, 2024

BUY
$41.71 - $52.9 $71,741 - $90,988
1,720 Added 4.0%
44,700 $2.05 Million
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $1.4 Million - $2.25 Million
42,980 New
42,980 $2.24 Million
Q3 2020

Nov 16, 2020

SELL
$14.68 - $19.12 $660,600 - $860,400
-45,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$14.93 - $19.83 $671,850 - $892,349
45,000 New
45,000 $681,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.8B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.